logo

For the Inventor, By the Inventor

Beckenham, United Kingdom

Karl Witold Franzmann

This inventor holds 12 USPTO granted patents. Top assignees: Glaxo Wellcome Inc., Burroughs Wellcome Co., Smithkline Beecham Corporation. Active years: 1990-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Karl Witold Franzmann. Retrieved from https://idiyas.com/inventor/karl-witold-franzmann

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12

% Patents Active = 100.0

Average Co-Inventor Count = 3.2

ph-index = 3

Forward Citations = 119(Granted Patents)


Location History:

  • Kent, GB (1990)
  • Beckenham, GB (1995 - 2000)
  • London, GB (1999 - 2007)

Company Filing History:

goldMedal5 out of 281 
 
Glaxo Wellcome Inc.
 patents
silverMedal2 out of 521 
 
Burroughs Wellcome Co.
 patents
bronzeMedal2 out of 2,198 
 
Smithkline Beecham Corporation
 patents
4. 1 out of 358 
 
Glaxosmithkline LLC
 patents
5. 1 out of 32 
 
The Wellcome Foundation Limited
 patents
6. 1 out of 136 
 
University College Cardiff Consultants Limited
 patents
7. 1 out of 705 
 
University of South Carolina
 patents
where one patent can have more than one assignee

Years Active: 1990-2007

Loading Chart...
12 patents (USPTO):Explore Patents
1. RE39576 - Enzyme inhibitors (2007-04-16),
2. 6620848 - Nitric oxide synthase inhibitors (2003-09-16),
3. 6369272 - Nitric oxide synthase inhibitors (2002-04-09),
4. 6169091 - Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors (2001-01-02),
5. 6043284 - Anti-atherosclerotic diaryl compounds (2000-03-28),
6. 5889056 - Enzyme inhibitors (1999-03-30),
7. 5874472 - Aminoacid derivatives as no synthase inhibitors (1999-02-23),
8. 5776951 - Anti-atherosclerotic diaryl compounds (1998-07-07),
9. 5679694 - Tetracyclic compounds, intermediates for their preparation and their use (1997-10-21),
10. 5658944 - Anti-atherosclerotic aryl compounds (1997-08-19),
11. 5422373 - Anti-atherosclerotic aryl compounds (1995-06-06),
12. 4968698 - Nitrogen containing heterocyclic compounds (1990-11-06),

Title: The Innovations of Karl Witold Franzmann

Introduction

Karl Witold Franzmann is a notable inventor based in Beckenham, GB. He has made significant contributions to the field of biochemistry, particularly in the development of enzyme inhibitors. With a total of 12 patents to his name, Franzmann's work has had a lasting impact on medical research and pharmaceutical development.

Latest Patents

Franzmann's latest patents include innovative compounds that serve as enzyme inhibitors. One of his notable inventions is a compound of formula (I) that functions as a nitric oxide synthase inhibitor. This advancement has potential applications in various therapeutic areas, showcasing his commitment to addressing complex health challenges.

Career Highlights

Throughout his career, Franzmann has worked with prominent companies in the pharmaceutical industry. He has been associated with Glaxo Wellcome Inc. and SmithKline Beecham Corporation, where he contributed to groundbreaking research and development projects. His expertise in biochemistry has positioned him as a key figure in the field.

Collaborations

Franzmann has collaborated with esteemed colleagues, including Harold Francis Hodson and Martin James Drysdale. These partnerships have fostered a collaborative environment that has led to significant advancements in their respective areas of research.

Conclusion

Karl Witold Franzmann's contributions to the field of biochemistry and his innovative patents highlight his role as a leading inventor. His work continues to influence the pharmaceutical industry and improve health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…